17 grants awarded to help commercialize Western Australian medical and health inventions

The Government of Western Australia has announced seed funding of $8 million to help continue medical and health innovations being developed in the state.

The first round of the Innovation Seed Fund has provided assistance to 17 publicly funded startups and institutes.

According to the website of the Future Health Research and Innovation Fund, through which the funding came, it would “support successful recipients to undertake activities to reduce risk and advance their innovations towards commercialization.”

A recipient (a complete list is reproduced below), VeinTech Technologies has received $500,000 to develop its prototype VeinWave device, which fits in the palm of the hand and helps visualize veins, making injections easier and more frequent.

The assistance would help develop “a commercial-ready, clinically compatible VeinWave prototype to reduce cannulation insertion failure.”

“This vital investment is supporting local innovators, but will also help spur innovation in health and medicine to improve the health and wellbeing of the Western Australian community,” the Minister for Health said on Sunday. Stephen Dawson Medical Research in a statement regarding the program’s inaugural cycle.

Image: The VeinTech team of Nikhilesh Bappoo, Nicholas Buckley and Dr Katherine Arenson (Image credit www.veintech.com.au)

Subscribe for free to our @AuManufacturing newsletter here.

(credit fhrifund.health.wa.gov.au)

Innovation team leader

Responsible entity

Project title

Funding granted

Mr Nikhilesh Bappoo VeinTech Pty Ltd Develop a commercial-ready and clinically compatible VeinWave prototype to reduce cannulation insertion failures $500,000
Acting Prof Jenny Downs Telethon Kids Institute on behalf of the Center for Child Health Research, UWA Detecting Pain in Children Who Can’t Tell You It Hurts: PainChek® for Children with Disabilities $392,820
Dr Sarah Doyle What The Doctor Said Pty Ltd An innovation to provide personalized, mobile-accessible discharge instructions for opioid medications for patients attending the Emergency Department, Ambulatory Care, and Outpatient Department of East Metropolitan Health Service Hospital $462,332
Professor Wendy Erber The University of Western Australia Precision diagnostics for blood cancers $499,632
Professor Sue Fletcher Murdoch University Modulation of the autophagy pathway to treat neurogenerative diseases $497,956
A/Professor Juliana Hamzah Curtin University A new drug to improve blood circulation in patients with peripheral arterial disease $496,715
Acting Prof Tim Inglis The University of Western Australia FAST STRIDES: Flow Cytometry-Assisted Antimicrobial Susceptibility Testing Software to Translate Innovative Diagnostics for the Treatment of Sepsis $497,190
Professor Terrance Johns Telethon Kids Institute on behalf of the Center for Child Health Research, UWA Redirect ion channel drugs to treat brain cancer $499,406
Professor Yogesan Kanagasingam Medivitals Pty Ltd AI-based remote monitoring platform with medical-grade wearable bioband technologies $383,250
Acting Professor Anthony Kicic Telethon Kids Institute Making bacteriophage therapy a reality: Implementing a new treatment pipeline to treat antimicrobial resistant infections $500,000
A/Professor Joost Lesterhuis Telethon Kids Institute on behalf of the Center for Child Health Research, UWA Activating the Power of Cancer Immunity Using Small Molecule Drugs $496,351
A/Professor Joost Lesterhuis Telethon Kids Institute on behalf of the Center for Child Health Research, UWA Intraoperative immunotherapy to prevent cancer recurrence after surgery $497,156
A/Prof Samuel Lundin Biotome Pty Ltd Development of Helitope, a precision immunological diagnostic to determine the risk of gastric cancer $497,000
Professor Bill Morgan AECONA Pty Ltd OcuLinx™: a portable hand-held device for non-invasive measurement of intracranial pressure via the eye $500,000
Dr Matthew Payne The University of Western Australia Refining a new molecular diagnostic test for the prediction of women at high risk of preterm birth $357,017
Assistant Professor Ming Yew Innova Medical Pty Ltd Getting rid of pus: a new medical device for the percutaneous treatment of skin abscesses on an outpatient basis $498,973
Professor Minghao Zheng The University of Western Australia Biotextile collagen cord as a new substitute for autografts for anterior cruciate ligament (ACL) reconstruction $484,396
TOTAL $8,060,194